Evidence map›Paper›PMID 29045398›Full record

ArticlePLoS biology2017

Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean.

Brandon S Razooky, Youfang Cao, Maike M K Hansen, Alan S Perelson, Michael L Simpson, Leor S Weinberger

Abstract read
In one paragraph

Article in PLoS biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Targeting HIV-1 proviral transcription.Current opinion in virology · 2019
    Review
  13. Post-Transcriptional Noise Control.BioEssays : news and reviews in molecular, cellular and developmental biology · 2019
    Article
  14. Article
  15. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brandon S RazookyLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.
Youfang CaoTheoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Maike M K HansenThe Gladstone Institutes (Virology and Immunology), San Francisco, California, United States of America.
Alan S PerelsonTheoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Michael L SimpsonCenter for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.
Leor S WeinbergerThe Gladstone Institutes (Virology and Immunology), San Francisco, California, United States of America.ORCID http://orcid.org/0000-0002-9987-6357

Funding

Modulating Stochastic Gene Expression for Cell-fate Control and TherapeuticsR37AI109593 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI WEINBERGER, LEOR S · 2021 to 2025
$6.2M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
Evolvable 'Resistance-Proof' TherapiesDP1DE024408 · NIDCR · J. DAVID GLADSTONE INSTITUTES · PI WEINBERGER, LEOR S · 2013 to 2017
$4.8M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
Immune System Modeling/HIVR37AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 2002 to 2011
$2.4M
Developing Transmissible Antivirals by Exploiting Gene-Expression CircuitryDP2OD006677 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINBERGER, LEOR S · 2009 to 2009
$2.3M
Stochastic Gene Expression in Retroviral LatencyR01AI109593 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI WEINBERGER, LEOR S · 2014 to 2018
$2.2M
NIAID NIH HHS R01 AI028433NIAID NIH HHS R01 AI109593NIAID NIH HHS R37 AI028433NIAID NIH HHS R37 AI109593NIDCR NIH HHS DP1 DE024408NIH HHS DP2 OD006677NIH HHS R01 OD011095
6 · The paper itself

Abstract

Fundamental to biological decision-making is the ability to generate bimodal expression patterns where 2 alternate expression states simultaneously exist. Here, we use a combination of single-cell analysis and mathematical modeling to examine the sources of bimodality in the transcriptional program controlling HIV's fate decision between active replication and viral latency. We find that the HIV transactivator of transcription (Tat) protein manipulates the intrinsic toggling of HIV's promoter, the long terminal repeat (LTR), to generate bimodal ON-OFF expression and that transcriptional positive feedback from Tat shifts and expands the regime of LTR bimodality. This result holds for both minimal synthetic viral circuits and full-length virus. Strikingly, computational analysis indicates that the Tat circuit's noncooperative "nonlatching" feedback architecture is optimized to slow the promoter's toggling and generate bimodality by stochastic extinction of Tat. In contrast to the standard Poisson model, theory and experiment show that nonlatching positive feedback substantially dampens the inverse noise-mean relationship to maintain stochastic bimodality despite increasing mean expression levels. Given the rapid evolution of HIV, the presence of a circuit optimized to robustly generate bimodal expression appears consistent with the hypothesis that HIV's decision between active replication and latency provides a viral fitness advantage. More broadly, the results suggest that positive-feedback circuits may have evolved not only for signal amplification but also for robustly generating bimodality by decoupling expression fluctuations (noise) from mean expression levels.

Indexed as

Feedback, PhysiologicalAlgorithmsFlow CytometryGene Expression Regulation, ViralGreen Fluorescent ProteinsHEK293 CellsHIV-1HIV InfectionsHIV Long Terminal RepeatHumansJurkat CellsMicroscopy, ConfocalModels, GeneticPromoter Regions, GeneticSingle-Cell AnalysisStochastic ProcessesGreen Fluorescent Proteinstat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID29045398
PMCPMC5646755

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.